(Q46143985)

19 December 2017

title

Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide (English)

1 reference

19 December 2017

author name string

M Nelson

series ordinal

1

1 reference

19 December 2017

D Nelson

series ordinal

2

1 reference

19 December 2017

publication date

1 January 1990

1 reference

19 December 2017

Cancer Immunology, Immunotherapy

published in

1 reference

19 December 2017

volume

30

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

331-341

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf01786882

exact match

0 references

cites work

Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01786882

Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01786882

Interleukin-2 production in head and neck cancer patients

21 January 2018

1 reference

12 December 2020

Natural killer cell activity and head and neck cancer: a clinical assessment

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Detection and cloning of murine leukemia virus-related sequences from African green monkey liver DNA

1 reference

12 December 2020

Immunotherapy of cancer using interleukin 2: current status and future prospects

1 reference

12 December 2020

Macrophages and resistance to tumors. IV. Influence of age on susceptibility of mice to anti-inflammatory and antimacrophage effects of tumor cell products

1 reference

12 December 2020

In vitro synthesis of laminin and entactin polypeptides

1 reference

12 December 2020

A direct comparison of procedures for the detection of mycoplasma in tissue culture

1 reference

12 December 2020

Specific hybridization probes demonstrate fewer xenotropic than mink cell focus-forming murine leukemia virus env-related sequences in DNAs from inbred laboratory mice

1 reference

12 December 2020

Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant

1 reference

12 December 2020

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose

1 reference

12 December 2020

Interleukin-2 augments natural killer cell activity

1 reference

12 December 2020

Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735

1 reference

12 December 2020

1 reference

12 December 2020

Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages

1 reference

12 December 2020

Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells

1 reference

12 December 2020

Prostaglandin synthesis in human T cells: its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation.

1 reference

12 December 2020

A Rapid Method for the Separation of Functional Lymphoid Cell Populations of Human and Animal Origin on PVP-Silica (Percoll) Density Gradients

1 reference

12 December 2020

Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients

1 reference

12 December 2020

Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses

1 reference

12 December 2020

Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products

1 reference

12 December 2020

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

12 December 2020

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

1 reference

12 December 2020

Characterization of an inhibitor of cell division released in tumour cell cultures

1 reference

12 December 2020

Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity

1 reference

12 December 2020

Amplification and chromosomal dispersion of human endogenous retroviral sequences.

1 reference

12 December 2020

Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.

1 reference

12 December 2020

Defective interleukin-1 production by natural killer cells of patients with cancer

1 reference

12 December 2020

Removal of gram-negative endotoxin from solutions by affinity chromatography

1 reference

12 December 2020

Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.

1 reference

12 December 2020

Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy

1 reference

12 December 2020

Human IFN-gamma production is inhibited by a synthetic peptide homologous to retroviral envelope protein

1 reference

12 December 2020

A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.

1 reference

12 December 2020

The mechanism of retrovirus suppression of human T cell proliferation in vitro

1 reference

12 December 2020

Collagen required for proliferation of cultured connective tissue cells but not their transformed counterparts

1 reference

12 December 2020

Inhibition of cell-mediated immunity by tumour cell products: depression of interleukin-2 production and responses to interleukin-2 by mouse spleen cells

1 reference

12 December 2020

Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity

1 reference

12 December 2020

Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.

1 reference

12 December 2020

Retroviral protein P15E and tumorigenesis. Expression is neither required nor sufficient for tumor development

1 reference

12 December 2020

Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

1 reference

12 December 2020

Cancer and subversion of host defences.

1 reference

12 December 2020

Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants

1 reference

12 December 2020

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Evasion of host defences by tumours

1 reference

12 December 2020

Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia

1 reference

12 December 2020

Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene

1 reference

12 December 2020

Mechanisms regulating the level of IL-2 mRNA in T lymphocytes

1 reference

12 December 2020

Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites

1 reference

12 December 2020

Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses

1 reference

12 December 2020

Characterization of an immunosuppressive factor derived from colon cancer cells

1 reference

12 December 2020

Inhibition of interleukin 2 production by factors released from tumor cells.

1 reference

12 December 2020

Inhibition of cytokine production by a tumor cell product.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01786882

1 reference

19 December 2017

PubMed ID

2302724

1 reference

19 December 2017